Fig. 1
Cav-1 expression in MPM and PA cases; a: strong and score 3 (positivity in >50%of tumor cells) expression in epitheloidmesothelioma (×100), b: strong and score 3 expression in biphasic mesothelioma (×100), c: weak and score 2 (positivity in 11–50% of tumor cells) expression in sarcomatoid mesothelioma (×100), d: negative Cav-1 expression in epitheloid mesothelioma (×100), e: negative Cav-1 expression in biphasic mesothelioma (×100), f: negative Cav-1 expression in sarcomatoid mesothelioma (×100), g:Moderate and score (1 positivity in 1–10% of tumor cells) expression in PA (×100), h and i: negative Cav-1 expression in PA (×100)